Literature DB >> 9627050

Expression analysis of the soluble and membrane-associated forms of the interleukin-1 receptor-related T1 protein in primary mast cells and fibroblasts.

D R Moritz1, J Gheyselinck, R Klemenz.   

Abstract

The murine T1 gene encodes a membrane-bound glycoprotein (T1M) and a soluble variant (T1S) which represents the ectodomain of the receptor-type form. T1 is an orphan receptor belonging to the interleukin-1 receptor family. Its biological function is currently unknown. We analyze the expression of the two T1 proteins in mast cells and fibroblasts by using a set of monoclonal antibodies (MAb) that specifically recognize the extracellular portion of the T1 receptor. To generate anti-T1 MAbs, we immunized Lewis rats with a eukaryotically expressed chimeric protein consisting of the T1-receptor ectodomain fused to a human immunoglobulin domain. The two MAbs DJ4 and DJ8 were shown to specifically detect the murine T1M protein on the surface of primary IL-3-dependent bone marrow-derived mast cells as shown by flow cytometry and immunohistochemistry. Both antibodies were also capable of immunoprecipitating the membrane-associated 110-120 kDa T1M protein from mast cell lysates. In serum-stimulated but not in quiescent NIH3T3 fibroblasts, DJ4 and DJ8 MAbs detected both the soluble T1S protein as a 45-65 kDa band on SDS polyacrylamide gels as well as the membrane-bound 95 kDa T1M protein. The T1M protein in fibroblasts was less abundantly expressed and exhibited a lower molecular weight than the mast cell-produced T1M, probably as a consequence of different protein glycosylation. The MAbs described here represent highly specific reagents and valuable tools that should facilitate the establishment of the murine T1 protein expression pattern thus contributing to the solution of the question of its function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627050     DOI: 10.1089/hyb.1998.17.107

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  7 in total

1.  GATA-Dependent expression of the interleukin-1 receptor-related T1 gene in mast cells.

Authors:  T Gächter; D R Moritz; J Gheyselinck; R Klemenz
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

2.  Identification of two distinct subpopulations of Leishmania major-specific T helper 2 cells.

Authors:  Pascale Kropf; Shanti Herath; Rita Tewari; Nelofer Syed; Roman Klemenz; Ingrid Müller
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.

Authors:  Markus Brunner; Claus Krenn; Georg Roth; Bernhard Moser; Martin Dworschak; Erika Jensen-Jarolim; Andreas Spittler; Thomas Sautner; Nico Bonaros; Ernst Wolner; George Boltz-Nitulescu; Hendrik Jan Ankersmit
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

4.  Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection.

Authors:  P Kropf; S Herath; R Klemenz; I Müller
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation.

Authors:  Tatsukuni Ohno; Keisuke Oboki; Hideaki Morita; Naoki Kajiwara; Ken Arae; Shizuko Tanaka; Masako Ikeda; Motoyasu Iikura; Taishin Akiyama; Jun-ichiro Inoue; Kenji Matsumoto; Katsuko Sudo; Miyuki Azuma; Ko Okumura; Thomas Kamradt; Hirohisa Saito; Susumu Nakae
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

6.  T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses.

Authors:  M J Townsend; P G Fallon; D J Matthews; H E Jolin; A N McKenzie
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

7.  The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function.

Authors:  K Hoshino; S Kashiwamura; K Kuribayashi; T Kodama; T Tsujimura; K Nakanishi; T Matsuyama; K Takeda; S Akira
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.